Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
Infection. 2023 Jun;51(3):641-654. doi: 10.1007/s15010-022-01904-w. Epub 2022 Sep 14.
Infection. 2023.
PMID: 36104613
Free PMC article.
Clinical Trial.
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Poulakou G, Barakat M, Israel RJ, Bacci MR; Virazole Collaborator Group for COVID-19 Respiratory Distress.
Poulakou G, et al.
Clin Transl Sci. 2023 Jan;16(1):165-174. doi: 10.1111/cts.13436. Epub 2022 Nov 3.
Clin Transl Sci. 2023.
PMID: 36326174
Free PMC article.
Item in Clipboard
Cite
Cite